Canada Markets close in 1 hr 55 mins

Thiogenesis Therapeutics, Corp. (TTI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.45000.0000 (0.00%)
As of 01:45PM EDT. Market open.
Full screen
Previous Close0.4500
Open0.4100
Bid0.4050 x N/A
Ask0.5000 x N/A
Day's Range0.4200 - 0.4700
52 Week Range0.4000 - 0.7000
Volume16,000
Avg. Volume28,625
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Thiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102

    Data demonstrates potential for less frequent drug administrationTTI-0102 was well tolerated with no Serious Adverse Events reportedSupports EU and US regulatory submissions for human efficacy trials in multiple disease indicationsSan Diego, California--(Newsfile Corp. - May 18, 2022) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing sulfur-containing therapeutics for serious pediatric diseases, today announces positi

  • CNW Group

    IIROC Trading Resumption - TTI

    Trading resumes in: